Middle East News Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Digest.

Press releases published on April 27, 2026

Apr. 27, 2026

Tenaya Therapeutics Announces Late-Breaking Oral Presentation of New Clinical Data from RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy in Adults with PKP2-Associated ARVC at ASGCT 2026

Indeterminate GlobeNewswire

Apr. 27, 2026

Critical Metals to Acquire European Lithium

Indeterminate GlobeNewswire

Apr. 27, 2026

First Atlantic Nickel Announces Name Change to First Atlantic Nickel & Cobalt Ahead of the Washington DC Safe Summit, Reinforcing the Natural Cobalt Content of Awaruite - a Rare, Naturally Magnetic (Ni-Fe-Co) Alloy That Is Sulfur-Free and Can Bypass…

Indeterminate GlobeNewswire

Apr. 27, 2026

Coinstore Set to List QIE, a High-Performance Layer 1 Blockchain Designed to Bridge Global Identity and Scalable Payments

Indeterminate GlobeNewswire

Apr. 27, 2026

Oncolytics Aligns with FDA on Planned Pivotal Anal Cancer Study

Indeterminate GlobeNewswire

Apr. 27, 2026

Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain Patients with Chronic Myeloid Leukemia

Indeterminate GlobeNewswire

Apr. 27, 2026

Ardelyx Announces Abstract Accepted for Poster Presentation at the NKF’s Spring Clinical Meetings

Indeterminate GlobeNewswire

Apr. 27, 2026

Avalyn Strengthens Leadership Team to Support Long-Term Growth with Appointments of Industry Leaders Adam Golden and Frank Salisbury

Indeterminate GlobeNewswire

Apr. 27, 2026

Replimune to Present at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

SONORO GOLD ANNOUNCES CLOSING OF OVERSUBSCRIBED $12.2M PRIVATE PLACEMENT

Indeterminate GlobeNewswire

Apr. 27, 2026

Apollomics Reports Full Year 2025 Financial Results and Provides Clinical Updates and Business Progress

Indeterminate GlobeNewswire

Apr. 27, 2026

Global-e to Announce Financial Results for the First Quarter 2026 on May 13, 2026

Indeterminate GlobeNewswire

Apr. 27, 2026

Clearmind Medicine Announces Evaluation of its Psychedelic-Based Treatment (MEAI) for Potential FDA Breakthrough Therapy Designation

Indeterminate GlobeNewswire

Apr. 27, 2026

NervGen Pharma Strengthens Leadership Team with Appointment of Keith Vendola as Chief Financial Officer

Indeterminate GlobeNewswire

Apr. 27, 2026

CorMedix Therapeutics Announces Positive Topline Results from Phase III ReSPECT Trial Assessing REZZAYO® for the Prophylaxis of Invasive Fungal Diseases in Allogeneic Hematopoietic Stem Cell Transplantation Patients

Indeterminate GlobeNewswire

Apr. 27, 2026

One Bullion Reports High Concentration of Gold During Artisanal Sampling Program at Vumba Project Which Yielded a 679 g/t Gold Sample

Indeterminate GlobeNewswire

Apr. 27, 2026

Allot to Release First Quarter 2026 Results and Host Conference Call on May 12, 2026

Indeterminate GlobeNewswire

Apr. 27, 2026

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2026

Indeterminate GlobeNewswire

Apr. 27, 2026

VR Resources Announces Closing of Oversubscribed $1.1M Brokered Private Placement Led by Centurion One Capital

Indeterminate GlobeNewswire

Apr. 27, 2026

Secura Bio Announces Journal of Clinical Oncology Publication of Final Results of Duvelisib PRIMO Phase 2 Trial in Relapsed/Refractory Peripheral T-cell Lymphoma

Indeterminate GlobeNewswire